117 related articles for article (PubMed ID: 35901507)
1. SLC38A6, regulated by EP300-mediated modifications of H3K27ac, promotes cell proliferation, glutamine metabolism and mitochondrial respiration in hepatocellular carcinoma.
Huang L; Li L; Cheng B; Xing T
Carcinogenesis; 2022 Oct; 43(9):885-894. PubMed ID: 35901507
[TBL] [Abstract][Full Text] [Related]
2. NDUFA8 is transcriptionally regulated by EP300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
Xiang H; Tang H; He Q; Sun J; Yang Y; Kong L; Wang Y
Biochem Biophys Res Commun; 2024 Jan; 693():149374. PubMed ID: 38096616
[TBL] [Abstract][Full Text] [Related]
3. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
4. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
6. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
7. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.
Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H
Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300.
Li F; Liang Y; Ying P
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468010
[TBL] [Abstract][Full Text] [Related]
9. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
Yang X; Liu L; Zou H; Zheng YW; Wang KP
Dig Liver Dis; 2019 Oct; 51(10):1446-1455. PubMed ID: 31147216
[TBL] [Abstract][Full Text] [Related]
10. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
11. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.
Cheng N; Li Y; Han ZG
Hepatology; 2013 May; 57(5):1906-18. PubMed ID: 23258480
[TBL] [Abstract][Full Text] [Related]
12. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
13. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
Liu G; Yang ZF; Sun J; Sun BY; Zhou PY; Zhou C; Guan RY; Wang ZT; Yi Y; Qiu SJ
Cell Oncol (Dordr); 2022 Dec; 45(6):1435-1449. PubMed ID: 36435866
[TBL] [Abstract][Full Text] [Related]
14. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Zhang Q; Wei T; Jin W; Yan L; Shi L; Zhu S; Bai Y; Zeng Y; Yin Z; Yang J; Zhang W; Wu M; Zhang Y; Peng G; Roessler S; Liu L
J Hepatol; 2024 Feb; 80(2):293-308. PubMed ID: 38450598
[TBL] [Abstract][Full Text] [Related]
16. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
Shi Y; Yan F; Wang F; Pan L
Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
19. SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis.
Xu K; Ding J; Zhou L; Li D; Luo J; Wang W; Shang M; Lin B; Zhou L; Zheng S
Cells; 2022 Dec; 12(1):. PubMed ID: 36611819
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
